The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...

Zevaskyn won FDA approval upon Abeona’s second filing of a biologics license application (BLA) for the therapy.

Scientists identified broadly neutralizing antitoxin antibodies in blood from snake venom-exposed hyperimmune donor for ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...

Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations.

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

Researchers say that while a new study has implications for neurodegenerative disease research, its more immediate impact ...

Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug ...

Researchers have identified a potential strategy to protect against Alzheimer’s by increasing the clusterin (CLU) protein, ...

LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

Merck KGaA said the deal will grow its U.S. presence and expand the reach of SpringWorks’ drugs, including one approved in ...